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Abstract
In this study, three different feature selection algorithms
are compared using Support Vector Machines as classifier
for cancer classification through gene expression data. The
ability of feature selection algorithms to select an optimal
gene subset for a cancer type is evaluated by the classifica-
tion ability of selected genes. A publicly available micro ar-
ray dataset is employed for gene expression values. Selected
gene subsets were able to classify subtypes of the considered
cancer type with high accuracies and showed that these fea-
ture selection methods were applicable for bio-marker gene
selection.
1. Introduction
The number of patients diagnosed with cancer is increasing
rapidly [1]. Currently, cancer diagnosis is practiced by using
image processing techniques, blood analysis and biopsies. Can-
cer is caused by the accumulation of excessive amount of dam-
aged cells. The behavior of the cancer differs from patient to pa-
tient and can only be explained by studying the origin. Cancer
begins in the cell, and cell structure is unique to each individual.
Therefore, there is not one specific drug, vaccine or treatment
to cure cancer permanently for all cancer patients. A genetic
approach to cancer is contributive in understanding the rela-
tion between gene and their products, identifying bio-marker
genes for targeted drug therapies and the effects of genes on
certain cell signaling pathways. Gene expression provides the
information of how active a gene is. Micro array is one of the
widely used measurement methods for gene expression. Gene
expression values obtained by micro arrays can be employed
in cancer diagnosis and the classification of cancer types [2].
Micro array datasets are employed for these purposes in many
studies. Different feature selection algorithms are employed for
the selection of bio-marker gene subsets. Statistical and ma-
chine learning classification methods are applied to micro ar-
ray dataset with and without feature selection. Many studies
were able to identify bio-marker genes for specific cancer types
or classify cancer types with high accuracies [3], [4]. In this
study, the aim is to classify and select the optimal gene sub-
sets for two subtypes of leukemia (Acute Myeloid Leukemia
and Acute Lymphoblastic Leukemia). Therefore, three filter
type feature selection methods and Support Vector Machines
are employed. Feature selection algorithms and classifier are
represented in the second section of the paper. The experimen-
tal results obtained from the feature selection algorithms and
classifier is represented in the third section.
2. Feature Selection Algorithms and
Classifier
Optimal gene subsets or bio-marker genes for a specific
type of cancers are important to understand the characteristics
of cancer and produce alternative drugs. There are three main
types of feature selection algorithms; filter, wrapper and en-
semble type. Filter type feature selection algorithms consider
the statistical relations in between features or feature to class
to select a feature or a subset of features. Wrapper type fea-
ture selection algorithms select a feature or a subset of features
up to a criterion and test these selected features with a learning
algorithm. Then, determine the value of feature subset accord-
ing to learning rate of the classifier. Ensemble feature selection
algorithms are a combination of filter and wrapper types. A
variety of feature selection algorithms are applicable to micro
array datasets [5]. Non parametric tests, information theoretic
approaches, probabilistic feature selection methods and genetic
algorithms are practiced by many scientists to select the opti-
mal genes [6-9]. Micro array datasets consist of small sample
size but thousands of gene expression values as features. This
characteristic of micro array data is a disadvantage in terms of
data analysis but suitable for the application of filter type fea-
ture selection algorithms. Since, micro array datasets are high
dimensional datasets, several feature selection algorithms are
applied, filter based feature selection algorithms, frequently. In
this study, ReliefF algorithm, Correlation based Feature Selec-
tion algorithm and t test statistic are employed as filter feature
selection methods. Even though, several feature selection meth-
ods are employed in a more comprehensive study by the authors
of this paper, results of the best three feature selection methods
are represented in this paper [10].
2.1. ReliefF Algorithm
Relief is a weight-based feature selection algorithm. Reli-
efF algorithm is more accurate and applicable to the incomplete
or multi class data version of the Relief algorithm. ReliefF al-
gorithm finds k nearest neighbors to calculate the near-hit and
near-miss values for the feature and makes an estimation using
the average information k-nearest neighbors. ReliefF algorithm
calculates a weight value to determine the significance of the
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feature by using the equation 1. Then, each feature is ranked
according to calculated weight [11].
Si = Si − diff (xi, near − hiti)2
+diff (xi, near −missi)2
(1)
2.2. Correlation Based Feature Selection Algorithm
Correlation based feature selection algorithm calculates a
weight by using the equation 2 and ranks the features according
to their class to feature or in between feature relations [12].
CFS =
kr¯cf√
k + k (k − 1) r¯ff
(2)
2.3. T test
T test statistic is a statistical value which defines the differ-
ences between two datasets. It is more suitable for the datasets
which have normal distribution and independent [13]. In this
study,absolute value of the t-test with pooled variance estimate
used as ranking criterion. The t value for the t-statistic is calcu-
lated by equation 3.
t =
μ1 − μ2
sp
√
1
N1
+ 1
N2
(3)
where sp is the pooled variance estimate calculated by equation
4.
s2p =
(N1 − 1) ∗ s21 + (N2 − 1) ∗ s22
N1 +N2 − 2 (4)
The adequacy of selected feature selection algorithms to
select optimal gene subset for cancer diagnosis and classifica-
tion is tested by employing Support Vector Machines for clas-
sification. Support vector machines are supervised learning
algorithms and widely employed for text, image recognition
and bioinformatics. They are applicable to linear or nonlinear
datasets. In this study, LibSVM library is employed to perform
classification with Support Vector Machines. LibSVM is a li-
brary which provides the application Support Vector Machine
on several software platforms and available for public utiliza-
tion [14].
3. Experimental Results
The performance of feature selection algorithms and clas-
sifier to classify two subtypes of leukemia is evaluated with re-
spect to classification accuracy and the number of selected fea-
tures. Even though high classification accuracy is important in
the case of cancer classification, the number of genes used for
classification is important as well. Most of the studies in this
research area were able to classify cancer types using less than
fifty genes as features for cancer type classification and can-
cer diagnosis with high accuracies. The micro array dataset
used in this study is comprised of 7,129 gene expression val-
ues which are collected from 72 samples [15]. Experiments
performed on both raw and pre-processed data. Feature selec-
tion algorithms were stable enough to choose same features for
raw and pre-processed data and pre-processing had no effect on
the feature selection. Therefore, only the results of raw data is
represented here. K-fold cross validation is employed to divide
the dataset into train and test sets with K being equal to ten.
Gene expression values in the micro array dataset are ranked
by using the feature selection algorithms. Top ranked hundred
genes are selected to classify the types of leukemia. Classifi-
cation is performed by taking chunks of genes from top ranked
hundred genes subset and testing the trained support vector ma-
chine with several number of different gene subsets. The best
classification accuracy and least number of genes is accepted as
successful classification result.
Table 1. CLASSIFICATION ACCURACY OF T TEST STATISTIC
FOR LEUKEMIA
Number of Features Kernel Type Classification Accuracy
1-10 Linear 100%
1-82 Polynomial 98.57%
1-20 Radial Basis Function 65.47%
1-10 Sigmoid 65.53%
Table 2. CLASSIFICATION ACCURACY OF RELIEFF ALGO-
RITHM FOR LEUKEMIA
Number of Features Kernel Type Classification Accuracy
1-19 Linear 97.32%
1-55 Polynomial 96.25%
1-46 Radial Basis Function 65.53%
1 Sigmoid 65.47%
Table 3. CLASSIFICATION ACCURACY OF CORRELATION
BASED FEATURE SELECTION ALGORITHM FOR LEUKEMIA
Number of Features Kernel Type Classification Accuracy
1-19 Linear 97.32%
1-55 Polynomial 96.25%
1-46 Radial Basis Function 65.53%
1 Sigmoid 65.47%
The employed feature selection algorithms performed with
accuracies above 90%. Even though each algorithm performed
with high classification accuracies, the best feature selection
method for leukemia subtype classification is t test statistic. T
test statistic reached a 100 % classification accuracy, using only
ten selected genes. Furthermore, rankings of three feature selec-
tion algorithms show us 26 similar genes commonly selected by
the algorithms and important for the classification of leukemia
subtypes.
4. Discussions and Conclusion
In this study, optimal gene subset for cancer classification
is obtained with three different feature selection algorithms and
support vector machine is employed for the performance eval-
uation. Even though, classification accuracy and the number of
selected genes for classification are the two main criteria for
the performance. biological relevancy of the selected genes
is important as well. Most commonly selected genes are re-
searched to find any biological relation to cancer development
or leukemia and several reference studies are found for most of
the genes. Further, selected genes can be studied to find more
biological connections between genes and leukemia. Figure 1
shows the gene expression values of most commonly selected
genes by all feature selection algorithms. The classification
ability of most commonly selected genes are represented clearly
in the figure 1. CD33 has an important role in the cell cycle of
myelomonocytic-derived cells and it can be seen that CD33 is
more active (yellow color/ 0.6 mean gene expression value) for
AML patients [16]. Similarly, transcription factor 3 (TCF3) has
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an important role in the production of E protein [17]. This pro-
tein is essential for B and T lymphocyte development and this
gene is more active for ALL patients as seen from the figure.
Fig. 1. Most Commonly Selected Gene Expression Values
The proposed method in this study and experimental results
conclude that filter feature selection methods might be useful
for determining the set of relevant genes for a given type of can-
cer and improve generalization accuracy of the classifier. The
commonly selected genes by the three feature selection algo-
rithm includes CD33, Cathepsin D and Cyclin D3 genes. CD33
is active in the pathway for apoptosis of myelomonocytic-
derived cells and further research of this gene may yield to tar-
geted drugs for AML patients [18]. Cathepsin D and Cyclin D3
have a role in p53 pathway. Since p53 is a tumor suppressor
gene and it is seen in more than 50% cancers, genes that affect
the regulation of p53 is important to understand the cancerous
cell dynamics [19-21]. Further research of all other selected
genes’ relation with leukemia may have great importance for
the diagnosis, treatment and the prognosis phases of cancer.
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